RAS–Pathway Mutation Profiles and Clinical Outcomes Among Patients With Colorectal Cancer
Somatic alterations in the RAS–RAF–MAPK and PI3K pathways are key in colorectal cancer (CRC), yet their distribution, co‐occurrence patterns, and clinical significance remain incompletely defined. We characterized RAS/MAPK‐ and PI3K‐pathway alterations in a large cohort and assessed their prognostic implications.